Search

Author/Creator Kawabata, Rumi

1. Acquired resistance to trastuzumab/pertuzumab or to T‐DM1 in vivo can be overcome by HER2 kinase inhibition with TAS0728. Issue 6 (30th April 2020)

Authors:
Irie, Hiroki; Kawabata, Rumi; Fujioka, Yayoi; Nakagawa, Fumio; Itadani, Hiraku; Nagase, Hideki; Ito, Kimihiro; Uchida, Junji; Ohkubo, Shuichi; Matsuo, Kenichi
Journal:
Cancer science
Issue:
Volume 111:Issue 6(2020)
Page Start:
2123
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Activity of TAS4464, a novel NEDD8 activating enzyme E1 inhibitor, against multiple myeloma via inactivation of nuclear factor κB pathways. Issue 12 (23rd October 2019)

Authors:
Muraoka, Hiromi; Yoshimura, Chihoko; Kawabata, Rumi; Tsuji, Shingo; Hashimoto, Akihiro; Ochiiwa, Hiroaki; Nakagawa, Fumio; Fujioka, Yayoi; Matsuo, Kenichi; Ohkubo, Shuichi
Journal:
Cancer science
Issue:
Volume 110:Issue 12(2019)
Page Start:
3802
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search